KWR:NYSEQuaker Houghton Analysis
Data as of 2026-08-10 - not real-time
$169.95
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Quaker Chemical Corporation is bullish at $169.95, with short-term averages leading the long-term ones. Across the trailing 30 sessions it gained 8.5%. RSI sits at 64.5, which reads as approaching overbought, and MACD momentum is bullish. Recent trading has carved out support near $137.18 and resistance around $175.07.
On valuation the read is fair — an earnings multiple of 30.5, absent a reliable peer benchmark. The average analyst target implies 10.4% above today's level. Revenue is growing at 10.2% on a 4.9% profit margin. The 1.25% dividend yield looks covered by current payout levels.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 37.1%, a beta of 1.37 and a maximum drawdown of 36.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 4/10 conviction.
On valuation the read is fair — an earnings multiple of 30.5, absent a reliable peer benchmark. The average analyst target implies 10.4% above today's level. Revenue is growing at 10.2% on a 4.9% profit margin. The 1.25% dividend yield looks covered by current payout levels.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 37.1%, a beta of 1.37 and a maximum drawdown of 36.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 4/10 conviction.
Top Market Events
Have you looked into how Quaker Chemical KWR performed internationally during the quarter ending June 2026?Quaker Chemical Corporation KWR target price: $221.Quaker Chemical’s latest analyst update comes with no changes to the existing price target, which keeps the...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 143.68
- MACD momentum is positive
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 143.68
- Analyst targets imply +10.4% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Analyst targets imply +10.4% versus the current price
- Revenue growth of +10.2%
- P/E ratio of 30.5
Key Metrics & Analysis
Financial Health
Revenue Growth10.20%
Profit Margin4.95%
P/E Ratio30.5
ROE7.17%
ROA4.10%
Debt/Equity66.91
P/B Ratio2.1
Op. Cash Flow$131.2M
Free Cash Flow$129.9M
Technical Analysis
TrendBullish
RSI64.5
Support$137.18
Resistance$175.07
MA 20$156.29
MA 50$151.86
MA 200$143.68
MACDBullish
VolumeIncreasing
Fear & Greed Index94.82
Valuation
Fair Value$103.76
Target Price$187.57
Upside/Downside10.37%
GradeFair
TypeBlend
Dividend Yield1.25%
Risk Assessment
Beta1.37
Volatility37.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.